{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:56:47Z","timestamp":1789354607473,"version":"build-2803163510"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ejrad.2019.03.008","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T14:36:14Z","timestamp":1552660574000},"page":"231-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"special_numbering":"C","title":["Nephrotoxicity of iodinated contrast media: From pathophysiology to prevention strategies"],"prefix":"10.1016","volume":"116","author":[{"given":"Anne-Laure","family":"Faucon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bobrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Cl\u00e9ment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2019.03.008_bib0005","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00330-011-2225-0","article-title":"Contrast media safety committee of European Society of Urogenital Radiology (ESUR). Contrast induced nephropathy: updated ESUR contrast media safety committee guidelines","volume":"21","author":"Stacul","year":"2011","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0010","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/ajkd.2002.32766","article-title":"Hospital-acquired renal insufficiency","volume":"39","author":"Nash","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0015","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jacc.2007.12.035","article-title":"Contrast-induced acute kidney injury","volume":"51","author":"McCullough","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0020","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.amjcard.2009.02.039","article-title":"Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention","volume":"103","author":"Jabara","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2215\/CJN.05200709","article-title":"Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting","volume":"5","author":"Mitchell","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1681\/ASN.2016010021","article-title":"Estimating the risk of radiocontrast-associated nephropathy","volume":"28","author":"Wilhelm-Leen","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjcard.2006.01.022","article-title":"CIN Consensus Working Panel. Risk prediction of contrast-induced nephropathy","volume":"98","author":"McCullough","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0040","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneph.2013.282","article-title":"Acute kidney injury-epidemiology, outcomes and economics","volume":"10","author":"Rewa","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0050","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.1996.03530430033035","article-title":"The effect of acute renal failure on mortality. A cohort analysis","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0055","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/01.CIR.0000016043.87291.33","article-title":"Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention","volume":"105","author":"Rihal","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0060","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/CIRCULATIONAHA.110.953851","article-title":"Contrast-induced acute kidney injury","volume":"122","author":"Solomon","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0065","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0735-1097(00)00917-7","article-title":"The prognostic implications of further renal function deterioration within 48h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency","volume":"36","author":"Gruberg","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0070","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0002-9343(97)00150-2","article-title":"Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality","volume":"103","author":"McCullough","year":"1997","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0075","first-page":"53","article-title":"Epidemiology of contrast induced nephropathy","volume":"4","author":"McCullough","year":"2003","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0080","doi-asserted-by":"crossref","DOI":"10.1038\/sj.ki.5000367","article-title":"Contrast medium-induced nephropathy: the pathophysiology","volume":"69","author":"Persson","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0085","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/eurheartj\/ehr494","article-title":"Contrast-induced kidney injury: mechanisms, risk factors, and prevention","volume":"33","author":"Seeliger","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0090","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehn197","article-title":"Contrast agents and renal cell apoptosis","volume":"29","author":"Romano","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0095","doi-asserted-by":"crossref","first-page":"F61","DOI":"10.1152\/ajprenal.2001.280.1.F61","article-title":"Proximal tubule cell response to radiographic contrast media","volume":"280","author":"Hardiek","year":"2001","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0100","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1440-1681.2011.05503.x","article-title":"Pathophysiology of renal tissue damage by iodinated contrast media","volume":"38","author":"Sendeski","year":"2011","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0105","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1038\/cddis.2011.38","article-title":"In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis","volume":"2","author":"Quintavalle","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0110","doi-asserted-by":"crossref","first-page":"F864","DOI":"10.1152\/ajprenal.00302.2013","article-title":"Iodinated contrast media cause direct tubular cell damage, leading to oxidative stress, low nitric oxide, and impairment of tubuloglomerular feedback","volume":"306","author":"Liu","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0115","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ndt\/14.2.342","article-title":"Comparative cytotoxicity of ionic and non-ionic radiocontrast agents on MDCK cell monolayers in vitro","volume":"14","author":"Schick","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.tox.2004.12.020","article-title":"X-Ray contrast media: an overview","volume":"209","author":"Christiansen","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0125","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/ndt\/13.4.911","article-title":"Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: role of hypertonicity","volume":"13","author":"Hiz\u00f3h","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0130","doi-asserted-by":"crossref","first-page":"F1592","DOI":"10.1152\/ajprenal.00471.2012","article-title":"Iodinated contrast media cause endothelial damage leading to vasoconstriction of human and rat vasa recta","volume":"303","author":"Sendeski","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0135","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/hy0202.103287","article-title":"Interaction of O2 and NO in the thick ascending limb","volume":"39","author":"Ortiz","year":"2002","journal-title":"Hypertension."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0140","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1152\/ajprenal.00102.2002","article-title":"Superoxide stimulates NaCl absorption by the thick ascending limb","volume":"283","author":"Ortiz","year":"2002","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0145","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1152\/ajprenal.00348.2004","article-title":"Superoxide enhances Na-K-2Cl co-transporter activity in the thick ascending limb","volume":"288","author":"Juncos","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0150","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/01.HYP.0000236646.83354.51","article-title":"Superoxide stimulates NaCl absorption in the thick ascending limb via activation of protein kinase C","volume":"48","author":"Silva","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0155","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2215\/CJN.02600607","article-title":"Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy","volume":"3","author":"Heyman","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/RLI.0b013e3181d2eed8","article-title":"Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy","volume":"45","author":"Heyman","year":"2010","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejrad.2011.02.003","article-title":"Viscosity of iodinated contrast agents during renal excretion","volume":"80","author":"Jost","year":"2011","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0170","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00330-005-0081-5","article-title":"Members of the Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR). Effects of iodinated contrast media on blood and endothelium","volume":"16","author":"Aspelin","year":"2006","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0175","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJM199503093321006","article-title":"Hypoxia of the renal medulla -its implications for disease","volume":"332","author":"Brezis","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0180","series-title":"American College of Radiology Committee on Drugs and Contrast Media, ACR Manual on Contrast Media, Version 10.3","year":"2018"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1148\/radiology.188.1.8511292","article-title":"Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media","volume":"188","author":"Barrett","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0190","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/sj.ki.5001887","article-title":"Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media","volume":"70","author":"Liss","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0195","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2006.02.073","article-title":"A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media","volume":"48","author":"McCullough","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0200","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jcin.2009.05.002","article-title":"The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials","volume":"2","author":"Reed","year":"2009","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0205","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/M15-1402","article-title":"Comparative effect of contrast media type on the incidence of contrast-induced nephropathy: a systematic review and meta-analysis","volume":"164","author":"Eng","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0210","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00330-017-5246-5","article-title":"Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines","volume":"28","author":"van der Molen","year":"2018","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0215","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/MAJ.0b013e318068ddf9","article-title":"Risk markers for contrast-induced nephropathy","volume":"334","author":"Toprak","year":"2007","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0220","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1148\/radiol.12111667","article-title":"Epidemiology of contrast material-induced nephropathy in the era of hydration","volume":"263","author":"Balemans","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0225","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.2215\/CJN.03470708","article-title":"Contrast-induced acute kidney injury: is there a risk after intravenous contrast?","volume":"3","author":"Solomon","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0230","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ahj.2013.02.013","article-title":"Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: risk comparison adjusted for patient characteristics by design","volume":"165","author":"Kooiman","year":"2013","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0235","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/RLI.0000000000000298","article-title":"Acute Kidney injury after intravenous versus intra-arterial contrast material administration in a paired cohort","volume":"51","author":"McDonald","year":"2016","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0240","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jacc.2007.03.058","article-title":"NHLBI Dynamic Registry Investigators. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention","volume":"50","author":"Laskey","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0245","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/02841850802050762","article-title":"Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention","volume":"49","author":"Nyman","year":"2008","journal-title":"Acta radiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0250","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0255","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.12121460","article-title":"Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis","volume":"267","author":"McDonald","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0260","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/radiol.13130775","article-title":"Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate","volume":"271","author":"McDonald","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0265","doi-asserted-by":"crossref","first-page":"h4395","DOI":"10.1136\/bmj.h4395","article-title":"Risk prediction models for contrast induced nephropathy: systematic review","volume":"351","author":"Silver","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0270","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0275","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00330-004-2591-y","article-title":"Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). In which patients should serum creatinine be measured before iodinated contrast medium administration?","volume":"15","author":"Thomsen","year":"2005","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0280","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1161\/CIRCULATIONAHA.109.919639","article-title":"Cystatin C and contrast-induced acute kidney injury","volume":"121","author":"Briguori","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0285","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1161\/CIRCULATIONAHA.112.103317","article-title":"Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury","volume":"126","author":"Quintavalle","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0290","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ki.1995.40","article-title":"Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine","volume":"47","author":"Newman","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0295","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","article-title":"Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis","volume":"40","author":"Dharnidharka","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0300","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5414\/CNP61098","article-title":"Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media","volume":"61","author":"Rickli","year":"2004","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0305","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2215\/CJN.00550109","article-title":"Contrast-induced nephropathy and long-term adverse events: cause and effect?","volume":"4","author":"Solomon","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0310","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/jcp.24267","article-title":"Kidney injury molecule-1: more than just an injury marker of tubular epithelial cells?","volume":"228","author":"Lim","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0315","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/apha.12054","article-title":"Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications","volume":"207","author":"Singer","year":"2013","journal-title":"Acta Physiol. (Oxf.)"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0320","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/RLI.0000000000000031","article-title":"Evaluation of intrarenal oxygenation in iodinated contrast-induced acute kidney injury-susceptible rats by blood oxygen level-dependent magnetic resonance imaging","volume":"49","author":"Li","year":"2014","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0325","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/sj.ki.5000371","article-title":"Dialysis and iodinated contrast media","volume":"100","author":"Deray","year":"2006","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0330","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/oxfordjournals.ndt.a027830","article-title":"Effect of haemodialysis after contrast medium administration in patients with renal insufficiency","volume":"13","author":"Lehnert","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0335","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0002-9343(01)00983-4","article-title":"Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful","volume":"111","author":"Vogt","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0340","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1093\/ndt\/gfs375","article-title":"A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy","volume":"27","author":"The ad-hoc working group of ERBP","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0345","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1007\/s00330-017-5247-4","article-title":"Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: recommendations for updated ESUR Contrast Medium Safety Committee guidelines","volume":"28","author":"van der Molen","year":"2018","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0350","series-title":"European Society of Urogenital Radiology, Contrast-Media Guidelines 10.0","year":"2018"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0355","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2215\/CJN.02580607","article-title":"Prevention of contrast-induced nephropathy with volume expansion","volume":"3","author":"Weisbord","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0360","doi-asserted-by":"crossref","first-page":"59K","DOI":"10.1016\/j.amjcard.2006.01.024","article-title":"CIN Consensus Working Panel. Strategies to reduce the risk of contrast-induced nephropathy","volume":"98","author":"Stacul","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0365","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1001\/jama.291.19.2328","article-title":"Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial","volume":"291","author":"Merten","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0370","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.2215\/CJN.11161012","article-title":"Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial","volume":"8","author":"Weisbord","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0375","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(17)30057-0","article-title":"Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial","volume":"389","author":"Nijssen","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0380","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1710933","article-title":"PRESERVE trial group. Outcomes after angiography with sodium bicarbonate and acetylcysteine","volume":"378","author":"Weisbord","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0385","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM200007203430304","article-title":"Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine","volume":"343","author":"Tepel","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0390","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ahj.2006.09.014","article-title":"N-acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses","volume":"153","author":"Vaitkus","year":"2007","journal-title":"Am. Heart J."},{"issue":"2011","key":"10.1016\/j.ejrad.2019.03.008_bib0395","first-page":"e574","article-title":"ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College Of Cardiology Foundation\/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0400","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.2174\/1568026614666141203130324","article-title":"Pleiotropic effects of statins in atherosclerotic disease: focus on the antioxidant activity of atorvastatin","volume":"14","author":"Profumo","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0405","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0195-668X(02)00419-0","article-title":"Statin effects beyond lipid lowering \u2013 are they clinically relevant?","volume":"24","author":"Bonetti","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0410","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0163-7258(03)00055-X","article-title":"The lipid and non-lipid effects of statins","volume":"99","author":"Wierzbicki","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0415","first-page":"851","article-title":"High-dose statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis","volume":"27","author":"Zhang","year":"2011","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0420","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5414\/CN106950","article-title":"Short-term, high-dose statins in the prevention of contrast-induced nephropathy: a systematic review and meta-analysis","volume":"76","author":"Zhou","year":"2011","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0425","article-title":"Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0430","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.amjcard.2014.05.036","article-title":"Meta-analysis of randomized controlled trials of pre-procedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterization","volume":"114","author":"Giacoppo","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0435","article-title":"Efficacy of short-term high-dose statin pretreatment in prevention of contrast-induced acute kidney injury: updated study-level meta-analysis of 13 randomized controlled trials","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0440","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.amjcard.2014.07.059","article-title":"Meta-analysis on efficacy of statins for prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography","volume":"114","author":"Ukaigwe","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0445","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcard.2015.01.046","article-title":"A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes","volume":"183","author":"Marenzi","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0450","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jcph.411","article-title":"Meta-analysis of short-term high versus low doses of atorvastatin preventing contrast-induced acute kidney injury in patients undergoing coronary angiography\/percutaneous coronary intervention","volume":"55","author":"Wu","year":"2015","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0455","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1074248414549462","article-title":"Statins for the prevention of contrast-induced nephropathy after coronary angiography \/ percutaneous interventions: a meta-analysis of randomized controlled trials","volume":"20","author":"Liu","year":"2015","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0460","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijcard.2011.08.047","article-title":"A meta-analysis of randomized trials for effects of periprocedural atorvastatin on contrast-induced nephropathy","volume":"153","author":"Takagi","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0465","doi-asserted-by":"crossref","first-page":"e1226","DOI":"10.1097\/MD.0000000000001226","article-title":"Rosuvastatin treatment for preventing contrast-induced acute kidney injury after cardiac catheterization: a meta-analysis of randomized controlled trials","volume":"94","author":"Yang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0470","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3109\/0886022X.2015.1010939","article-title":"Periprocedural effects of statins on the incidence of contrast-induced acute kidney injury: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Cheungpasitporn","year":"2015","journal-title":"Ren. Fail."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0475","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijcard.2016.01.004","article-title":"Periprocedural effects of statins on the incidence of contrast-induced acute kidney injury: a systematic review and trial sequential analysis","volume":"206","author":"Wang","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"13","key":"10.1016\/j.ejrad.2019.03.008_bib0480","doi-asserted-by":"crossref","first-page":"p173","DOI":"10.1016\/S0735-1097(16)30174-7","article-title":"High-dose statin therapy is effective at preventing the development of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a meta-analysis","volume":"67","author":"Zografos","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0485","doi-asserted-by":"crossref","first-page":"e7384","DOI":"10.1097\/MD.0000000000007384","article-title":"Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: a meta-analysis of 15 randomized controlled trials","volume":"96","author":"Liang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0490","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjcard.2009.04.014","article-title":"Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"104","author":"Xinwei","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2011.03.001","volume":"108","author":"Patti","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0500","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jacc.2013.04.105","volume":"63","author":"Leoncini","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0505","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jacc.2013.09.017","article-title":"Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease","volume":"63","author":"Han","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"499","key":"10.1016\/j.ejrad.2019.03.008_bib0510","first-page":"e1","article-title":"Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial - a randomized controlled study","volume":"155","author":"Jo","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0515","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.amjcard.2009.09.026","article-title":"Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease","volume":"105","author":"Toso","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0520","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1742-1241.2010.02588.x","article-title":"Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials","volume":"65","author":"Zhang","year":"2011","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0525","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijcard.2011.05.045","article-title":"Effect of statin therapy on contrast-induced nephropathy after coronary angiography: a meta-analysis","volume":"151","author":"Pappy","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0530","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000326269","article-title":"Statins for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis","volume":"33","author":"Zhang","year":"2011","journal-title":"Am. J. Nephrol."},{"issue":"2014","key":"10.1016\/j.ejrad.2019.03.008_bib0535","first-page":"2541","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0540","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJM199411243312104","article-title":"Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents","volume":"331","author":"Solomon","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0545","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/ndt\/gfl133","article-title":"A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients","volume":"21","author":"Dussol","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0550","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.ajkd.2009.03.024","article-title":"Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial","volume":"54","author":"Majumdar","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0555","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","article-title":"Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium","volume":"74","author":"Murry","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0560","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0140-6736(09)61421-5","article-title":"Translation of remote ischaemic preconditioning into clinical practice","volume":"374","author":"Kharbanda","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0565","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/ki.1991.58","article-title":"The cell biology of ischemic renal injury","volume":"39","author":"Weinberg","year":"1991","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0570","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ejcts.2008.07.062","article-title":"Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomized clinical trials","volume":"34","author":"Walsh","year":"2008","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0575","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/CCM.0000000000001381","article-title":"Remote ischemic preconditioning and protection of the kidney \u2013 a novel therapeutic option","volume":"44","author":"Zarbock","year":"2016","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0580","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/ALN.0000000000001598","article-title":"Long-term effects of remote ischemic preconditioning on kidney function in high-risk cardiac surgery patients: follow-up results from the renal RIP trial","volume":"126","author":"Zarbock","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0585","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.112.096370","article-title":"Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot Ren Pro Trial (Renal Protection Trial)","volume":"126","author":"Er","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0590","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejvs.2015.04.002","article-title":"Remote ischemic preconditioning to reduce contrast-induced nephropathy: a randomized controlled trial","volume":"50","author":"Menting","year":"2015","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0595","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0735-1097(98)00574-9","article-title":"A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast induced Nephropathy Clinical Evaluation","volume":"33","author":"Stevens","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0600","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCULATIONAHA.111.030759","article-title":"REMEDIAL II investigators. Renal insufficiency after contrast media administration trial II (REMEDIALII): renal guard system in high-risk patients for contrast-induced acute kidney injury","volume":"124","author":"Briguori","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejrad.2019.03.008_bib0605","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcin.2016.11.006","article-title":"Prevention of contrast-induced acute kidney injury by furosemide with matched hydration in patients undergoing interventional procedures: a systematic review and meta-analysis of randomized trials","volume":"10","author":"Putzu","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ejrad.2019.03.008_bib0610","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcin.2011.08.017","article-title":"Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (induced diuresis with matched hydration compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial","volume":"5","author":"Marenzi","year":"2012","journal-title":"JACC Cardiovasc. Interv."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X19300993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X19300993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:15:16Z","timestamp":1759994116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X19300993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":122,"alternative-id":["S0720048X19300993"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2019.03.008","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nephrotoxicity of iodinated contrast media: From pathophysiology to prevention strategies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2019.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}